Galileo Resources (GLR) reported on laboratory assays from the recent reverse circulation (“RC”) drilling completed on its 100% owned prospecting licence PL253 in the Kalahari Copperbelt (“KCB”) of Botswana. This follows from the Company’s announcement of 1 September 2025 in which positive indications of intermittent visible copper mineralisation were reported at PL253. GLR said “We are pleased to be awarded renewal of the strategically positioned prospecting licence PL253 in the Kalahari Copperbelt. The fact that we have encountered copper mineralisation over an extensive interval in our first reconnaissance drilling programme testing a soil target is very encouraging. The combination of position and prospectivity provides us with strong motivation to continue exploration on this licence.”
Comment: These should be perfect times for companies like GLR, and of course for all the Colin Bird stable listed on the London market. The KCB is particularly prospective, and particularly favoured currently. The only thing missing for GLR is for its shares to catch up with the generally stock market recovery in explorers / developers.
Kromek Group plc (KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, announces its unaudited interim results for the six months ended 31 October 2025. Revenue increased substantially to £15.0m (H1 2025: £3.7m). Advanced Imaging revenue of £10.8m; revenue of £2.5m excluding Siemens Healthineers contribution, representing a 41% increase on an underlying basis (H1 2025: £1.7m). CBRN Detection revenue more than doubled to £4.3m (H1 2025: £2.0m). Gross margin improved to 71.7% (H1 2025: 56.9%). Adjusted EBITDA* of £6.0m (H1 2025: £2.3m loss).
Comment: We have a lap of honour RNS from KMK, something which because it has been years in the making is all the more welcome. The Siemens connection, plus the explosion of interest in all things defence and security related, makes the company a compelling growth contender.
Astrid Intelligence PLC (AQSE: ASTR), an operating company focused on decentralised artificial intelligence and blockchain infrastructure, announced that it has acquired TaoFi, a decentralised exchange and liquidity infrastructure platform operating within the Bittensor ecosystem from Subnet 10.
Comment: It is amazing that there can be positive sentiment towards a company does not understand an iota of, and negative sentiment towards a company everyone thinks they are an expert on, but are not.
Nyce International plc (AQUIS: NYCE) announced its unaudited management accounts reports for the quarters ended 31 December 2025 and 30 September 2025. NYCE said ” We have kicked off the new year in great fashion by forming our 3rd investment venture – “Innovassion”, which will operate as a standalone software development company under NYCE’s commercial guidance and leveraging NYCE’s global network, industry relationships, and market access. This new venture will focus on building scalable online casino solutions, proprietary gaming content, and modular iGaming technology designed to meet the needs of operators across regulated and emerging markets. Looking further ahead to Q1 2026, NYCE will build on this quarter’s achievements by expanding our digital marketplace and advisory services, while establishing the footprint of Innovassion, our iGaming software company with integrated games, sportsbook, and payment modules. As a core part of NYCE’s ecosystem, it supports operator growth, drives innovation, and creates long-term shareholder value beyond ClickSpin and Nirmata Play. The Board and I remain focused on strengthening our partner network, scaling operations, and pursuing initiatives that deliver tangible results for clients and lasting value for shareholders.”
Comment: NYCE remains one of the more under-appreciated companies on Aquius, something which belies the multi-faceted business and the potential with regard to the new / digital economy. Currently, at a dirt cheap valuation, the prospect of scaling up in 2026 keeps the company on the Zaks Traders Cafe radar.
Predator Oil & Gas Holdings Plc (PRD), the Jersey based Oil and Gas Company with producing hydrocarbon operations focussed on Trinidad and Morocco, announce that it has raise £4.5 million at 3.5p. The placing was completed by Albr Capital Limited and Oak Securities, acting jointly. “Trinidad is a re-emerging oil and gas province for the oil majors again fuelled by successes offshore Guyana and the new strategic importance of nearby Venezuela. We intend to increase further our visibility in Trinidad through advancing the drilling of SC-3. We have taken this opportunity to raise funds in order to undertake additional discretionary activity, strengthening the balance sheet, and enhancing production growth. Furthermore, demonstrating our operational experience and know-how gives us greater leverage to attract oil majors into our assets at some point. The offshore Guyana petroleum system extends into our licences. The TGB-6 fan in Morocco is geologically similar to the large biogenic gas fields of the East Mediterranean. Demonstrating materiality will be an important consideration for any potential farminee but recent geo-political developments have enhanced the potential for M & A consolidation”.
Comment: Just when one might have thought that PRD was fully funded, the share price could rise, and it might eventually discover / produce, the company is even more fully funded. Hopefully, one day soon it will find the big on, whether in Trinidad, Morocco, or in a back garden near you.
MYCELX Technologies Corporation (MYX), the clean water and clean air technology company, is pleased to provide a year-end financial update, reporting expected profitability that significantly exceeds market expectations, along with an update on the Company’s strategy for its core markets. The Company expects FY2025 year-end revenue of c.a. $11.7 million, a 140% improvement over FY2024, although slightly less than market expectations of $12.5 million.
Comment: Shares of MYX have been in basing mode since April, and now look set to build on the breakout through 30p. Ideally, even falling slightly shy of market expectations, the company is seen as having done enough to prove itself to be “on its way.”
genedrive plc (GDR), the point of care pharmacogenetic testing company, today announced that David Nugent and Robert English, a significant shareholder in the Company, have informed the Company that they intend to subscribe for £1.5m each (£3m in total) in new equity as part of a broader equity financing of up to £6.0m to fund the Company’s various growth initiatives.
Comment: It is to be hoped that this time the funds raised do not simply go to biotech experiment heaven, and instead build real shareholder value at a time when the sector is hot. The fact that the shares are 5x up on October lows suggests the market thinks this could be a turnaround situation.
Funding Circle Holdings (FCH) announced a Full Year 2025 Trading Update (unaudited). The Group has outperformed expectations for the year with revenue of c.£204 million, up 28% year on year, and profit before tax of c.£20 million (FY 2024: £3 million), ahead of current market expectations of £191 million and £17 million respectively. Overall credit extended for the year was £2.5 billion, an increase of 29% from FY 2024, and balances under management were £3.0 billion (FY 2024: £2.8 billion).
Comment: We have known for quite some time that FCH was flourishing in its space. But the share price reaction today on the upside underlines the way that the market was waiting to be reminded of just how well things are going. A return to five year highs towards 160p – 170p looks to be on the cards by the end of Q1 2026.
